Literature DB >> 35975261

ADRENAL HISTOPLASMOSIS: AN EASTERN INDIAN PERSPECTIVE.

S S Agrawal1, P P Chakraborty1, A Sinha1, A Maiti1, M Chakraborty2.   

Abstract

Context: The clinical presentation of histoplasmosis is varied. Due to its propensity for adrenal involvement, histoplasmosis is an important differential diagnosis in any patient presenting with adrenal mass, bilateral in particular. Objective: Data on clinical presentation, pattern of adrenal involvement, radiological appearance and long-term follow-up of adrenal histoplasmosis are relatively sparse; hence we looked at it. Design: This record based single-centre retrospective study was conducted in one of the tertiary care hospitals, situated in eastern India catering the Gangetic delta. Subjects and methods: Data on demographic characters, presenting manifestations, biochemical & hormonal parameters and radiological appearance of confirmed adrenal histoplasmosis cases (n=9), admitted between 2015-2019 have been retrieved. The treatment outcome and condition of patients after 1-4 years of follow-up has also been discussed.
Results: Four out of the nine (44.4%) patients had predisposing immunocompromised conditions in the form of diabetes and/or chronic alcoholism while rest were immunocompetent. Seven out of nine patients (77.8 %) had signs and symptoms suggestive of adrenal insufficiency, while two (22.2%) presented with only pyrexia of unknown origin. All of them had bilateral adrenal mass, though the radiologically appearances were different. All patients received anti-fungal agents with/without hydrocortisone and/or fludrocortisone. One patient died (11.1%), while majority responded favourably to treatment. Adrenocortical function did not recover completely. Conclusions: The possibility of adrenal histoplasmosis should always be considered in patients presenting with bilateral adrenal mass, irrespective of adrenal morphology. Treatment is effective, but many of them require supplemental hydrocortisone for quite a long period, if not lifelong. Mineralocorticoid deficiency, however, is not permanent. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Adrenal histoplasmosis; Bilateral adrenal mass; Primary adrenal insufficiency; Subclinical adrenal insufficiency

Year:  2022        PMID: 35975261      PMCID: PMC9365407          DOI: 10.4183/aeb.2022.106

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  30 in total

1.  Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man.

Authors:  W Oelkers; T Boelke; V Bähr
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

2.  Bilateral adrenal masses due to histoplasmosis.

Authors:  Jagat J Mukherjee; Michael L Villa; Lenny Tan; K O Lee
Journal:  J Clin Endocrinol Metab       Date:  2005-12       Impact factor: 5.958

Review 3.  A Twenty-First-Century Perspective of Disseminated Histoplasmosis in India: Literature Review and Retrospective Analysis of Published and Unpublished Cases at a Tertiary Care Hospital in North India.

Authors:  Ayush Gupta; Arnab Ghosh; Gagandeep Singh; Immaculata Xess
Journal:  Mycopathologia       Date:  2017-10-27       Impact factor: 2.574

Review 4.  Hormones and the resistance of women to paracoccidioidomycosis.

Authors:  Jata Shankar; Angela Restrepo; Karl V Clemons; David A Stevens
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 5.  Histoplasmosis in Australia: report of 16 cases and literature review.

Authors:  Donald S A McLeod; Robin H Mortimer; Donald A Perry-Keene; Anthony Allworth; Marion L Woods; Joanna Perry-Keene; William J H McBride; Christopher Coulter; Jennifer M B Robson
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

Review 6.  Histoplasmosis.

Authors:  Lawrence J Wheat; Marwan M Azar; Nathan C Bahr; Andrej Spec; Ryan F Relich; Chadi Hage
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

7.  Clinical outcomes and cortical reserve in adrenal histoplasmosis-A retrospective follow-up study of 40 patients.

Authors:  Mahaveer Singh; David D Chandy; Tamnay Bharani; Rungmei S K Marak; Subhash Yadav; Preeti Dabadghao; Sushil Gupta; Saroj K Sahoo; Rakesh Pandey; Eesh Bhatia
Journal:  Clin Endocrinol (Oxf)       Date:  2019-02-10       Impact factor: 3.478

8.  Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.

Authors:  L Joseph Wheat; Alison G Freifeld; Martin B Kleiman; John W Baddley; David S McKinsey; James E Loyd; Carol A Kauffman
Journal:  Clin Infect Dis       Date:  2007-08-27       Impact factor: 9.079

Review 9.  Endocrine and metabolic manifestations of invasive fungal infections and systemic antifungal treatment.

Authors:  Michail S Lionakis; George Samonis; Dimitrios P Kontoyiannis
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616

10.  Sub-clinical addison's disease.

Authors:  Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.